Lung Cancer Study Under Fire | GenomeWeb

Lung Cancer Study Under Fire

Premium

It's a well-known fact that researchers who want to conduct experiments on human subjects must get informed consent from each of the partcipants, acknowledging the risks of said experiments, says The New York Times' Gardiner Harris. But the researchers who conducted a "controversial" and "widely publicized" lung cancer study in 2006, which involved more than 50,000 participants, say they can't locate about 90 percent of the consent forms, Harris says.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.